Flexible and transparent platform based on oxide transistors for detection and readout of ionizing radiation
FLETRAD aims to develop a flexible, transparent radiation sensing platform using oxide transistors, addressing market needs in healthcare and safety while enabling high-resolution detection.
Projectdetails
Introduction
Ionizing radiation presents a known health risk, but if used controllably, it can be the basis of relevant applications spanning from healthcare to civil security. Either for proper control of the dose received by patients in medical treatments or workers in radiation hazardous environments, or for high-resolution imagers, proper quantification of the radiation doses is demanded.
Market Overview
The x-ray detectors market represented 2.5 Bn$ in 2020, and flexible/wearable X-ray detectors are seen as breakthrough innovations for next-gen devices. However, to date, there is not a detection technology offering a combination of:
- Conformability
- Portability
- Large active area
- Small interference with the radiation received
- Potential for high resolution
- Low cost/complexity
Proposed Solution
By using the patented idea of oxide transistors as direct ionization radiation detectors, coupled with the knowledge derived from ERC Starting Grant TREND in miniaturized oxide electronics using sustainable materials and processes, FLETRAD proposes a platform tackling all those requirements and going beyond them.
It creates the breakthrough market opportunity of having a fully flexible and transparent radiation sensing platform, using seamlessly integrated oxide transistors both for sensors and electronics.
Action Plan
The action intends to:
- Identify the most significant market opportunities/applications for the innovative platform.
- Fabricate/validate a prototype attractive to stakeholders.
- Develop an IP strategy and a business plan, including a detailed analysis of the identified business opportunities.
The work will be done at CENIMAT|I3N (NOVA), in a group pioneering oxide electronics, with full support from the Innovation Research and Impact Strategy (IRIS) office at NOVA.
Collaboration and Support
FLETRAD has the support of key players in ionizing radiation and flexible electronics, contributing to taking our ideas into impactful market and societal needs.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-10-2022 |
Einddatum | 30-6-2024 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- NOVA ID FCT - ASSOCIACAO PARA A INOVACAO E DESENVOLVIMENTO DA FCTpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Miniaturized flexible batteries for next generation wearable healthcare sensorsFlexiMin aims to develop a flexible, miniaturized battery to power next-gen wearable sensors for continuous biomarker monitoring, enhancing healthcare diagnostics and market readiness. | ERC Proof of... | € 150.000 | 2025 | Details |
Advanced imaging system for Medical ApplicationsThe i-TED project aims to demonstrate the applicability of a gamma-ray imaging system in intraoperative Radio-Guided Surgery and neutron dose assessment in boron-neutron capture therapy. | ERC Proof of... | € 150.000 | 2023 | Details |
Wafer scale dielectrics on two-dimensional semiconductors for high-performance field effect transistorsThis project aims to commercialize high-performance MoS2/ZrO2 FETs for ultra-sensitive sensors by demonstrating wafer-scale fabrication and conducting market assessments for industrial adoption. | ERC Proof of... | € 150.000 | 2025 | Details |
Direct detection of coherent signals using Fano devicesThis project aims to develop low-energy Fano Detectors for high-speed datacenter interconnects, culminating in a portable demo unit and a business plan for a start-up transceiver product. | ERC Proof of... | € 150.000 | 2022 | Details |
Radiation-detected NMR: new dimension for Magnetic Resonance spectroscopy and imagingThis project aims to develop a modular insert for conventional NMR and MRI spectrometers to enhance sensitivity through in-situ polarisation of longer-lived nuclei using radiation-detected NMR. | ERC Proof of... | € 150.000 | 2023 | Details |
Miniaturized flexible batteries for next generation wearable healthcare sensors
FlexiMin aims to develop a flexible, miniaturized battery to power next-gen wearable sensors for continuous biomarker monitoring, enhancing healthcare diagnostics and market readiness.
Advanced imaging system for Medical Applications
The i-TED project aims to demonstrate the applicability of a gamma-ray imaging system in intraoperative Radio-Guided Surgery and neutron dose assessment in boron-neutron capture therapy.
Wafer scale dielectrics on two-dimensional semiconductors for high-performance field effect transistors
This project aims to commercialize high-performance MoS2/ZrO2 FETs for ultra-sensitive sensors by demonstrating wafer-scale fabrication and conducting market assessments for industrial adoption.
Direct detection of coherent signals using Fano devices
This project aims to develop low-energy Fano Detectors for high-speed datacenter interconnects, culminating in a portable demo unit and a business plan for a start-up transceiver product.
Radiation-detected NMR: new dimension for Magnetic Resonance spectroscopy and imaging
This project aims to develop a modular insert for conventional NMR and MRI spectrometers to enhance sensitivity through in-situ polarisation of longer-lived nuclei using radiation-detected NMR.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
In-situ & operando organiC electrochemical transistors monitored by non-destructive spectroscopies for Organic cmos-like NeuromorphIc CircuitsICONIC aims to advance implantable AI organic electronic devices for chronic disease management by investigating PMIECs, leading to smart drug-delivery systems with enhanced accuracy and safety. | EIC Pathfinder | € 2.664.940 | 2024 | Details |
Perovskite Photon Counting X-ray Detectors for Medical Imaging.Clarity Sensors is developing advanced photon-counting detectors using halide perovskite semiconductors to enhance X-ray imaging resolution while reducing radiation dose, aiming for widespread adoption in clinical settings. | EIC Transition | € 2.494.268 | 2025 | Details |
Röntgentechnologie; een doorkijk naar de toekomstige mogelijkhedenInner B.V. ontwikkelt duurzame röntgentechnologie voor de levensmiddelenindustrie om contaminanten efficiënter te detecteren. | Mkb-innovati... | € 20.000 | 2023 | Details |
Radically New Cancer Therapy Based on Advances in Nanotechnology and Photonics for Simultaneous Imaging and Treatment of Solid TumoursScanNanoTreat aims to revolutionize cancer treatment by integrating advanced imaging and therapy technologies to improve patient outcomes and reduce costs, targeting clinical trials by 2027. | EIC Transition | € 2.499.911 | 2025 | Details |
Foundation Model-Based Biomarker Platform for Radiology and Clinical TrialsFoundRa aims to revolutionize radiology with an AI platform that accelerates precision medicine by generating scalable biomarkers and supporting radiologists in clinical trials and diagnostics. | EIC Accelerator | € 2.499.875 | 2024 | Details |
In-situ & operando organiC electrochemical transistors monitored by non-destructive spectroscopies for Organic cmos-like NeuromorphIc Circuits
ICONIC aims to advance implantable AI organic electronic devices for chronic disease management by investigating PMIECs, leading to smart drug-delivery systems with enhanced accuracy and safety.
Perovskite Photon Counting X-ray Detectors for Medical Imaging.
Clarity Sensors is developing advanced photon-counting detectors using halide perovskite semiconductors to enhance X-ray imaging resolution while reducing radiation dose, aiming for widespread adoption in clinical settings.
Röntgentechnologie; een doorkijk naar de toekomstige mogelijkheden
Inner B.V. ontwikkelt duurzame röntgentechnologie voor de levensmiddelenindustrie om contaminanten efficiënter te detecteren.
Radically New Cancer Therapy Based on Advances in Nanotechnology and Photonics for Simultaneous Imaging and Treatment of Solid Tumours
ScanNanoTreat aims to revolutionize cancer treatment by integrating advanced imaging and therapy technologies to improve patient outcomes and reduce costs, targeting clinical trials by 2027.
Foundation Model-Based Biomarker Platform for Radiology and Clinical Trials
FoundRa aims to revolutionize radiology with an AI platform that accelerates precision medicine by generating scalable biomarkers and supporting radiologists in clinical trials and diagnostics.